HA
HHLR Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,929,708
| Closed | -$185M | – | 87 |
|
|
2021
Q2 | $185M | Sell |
2,929,708
-1,628,321
| -36% | -$103M | 1.91% | 16 |
|
|
2021
Q1 | $196M | Sell |
4,558,029
-470,260
| -9% | -$20.2M | 1.93% | 15 |
|
|
2020
Q4 | $288M | Hold |
5,028,289
| – | – | 2.29% | 14 |
|
|
2020
Q3 | $152M | Hold |
5,028,289
| – | – | 1.15% | 17 |
|
|
2020
Q2 | $164M | Hold |
5,028,289
| – | – | 1.5% | 13 |
|
|
2020
Q1 | $135M | Buy |
5,028,289
+350,000
| +7% | +$9.38M | 1.82% | 16 |
|
|
2019
Q4 | $143M | Hold |
4,678,289
| – | – | 1.78% | 16 |
|
|
2019
Q3 | $113M | Buy |
4,678,289
+2,098,581
| +81% | +$50.6M | 1.55% | 17 |
|
|
2019
Q2 | $65.4M | Hold |
2,579,708
| – | – | 1.46% | 19 |
|
|
2019
Q1 | $50.3M | Buy |
2,579,708
+350,000
| +16% | +$6.82M | 1.4% | 17 |
|
|
2018
Q4 | $29.4M | Buy |
+2,229,708
| New | +$29.4M | 1.22% | 18 |
|